The Naloxone Hydrochloride Intranasa, cataloged under National Stock Number 6505-01-658-2463, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Emergent Devices, Inc.. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-658-2463 |
| Primary Part Number | NDC69547-0353-02 |
| Item Name | Naloxone Hydrochloride Intranasa |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Emergent Devices, Inc. |
| Status | ACTIVE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC45802-0578-84 | Padagis Us Llc Dba Perrigo Minnesota (USA) |
| NDC69547-0353-02 PRIMARY | Emergent Devices, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NARCAN 4MG NASAL SPRAY | 5/1 Secondary reference Emergent Devices, Inc. |
| 6505NCM163166 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1430155 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-658-2463 is a Naloxone Hydrochloride Intranasa, manufactured by Emergent Devices, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-658-2463 has 2 manufacturer part numbers on file: NDC45802-0578-84 (Padagis Us Llc Dba Perrigo Minnesota), NDC69547-0353-02 (Emergent Devices, Inc.).
Key specifications for NDC69547-0353-02: Special Features: NARCAN (NALOXONE HYDROCHLORIDE) NASAL SPRAY IS A PRE-FILLED, SINGLE DOSE INTRANASAL SPRAY INDICATED FOR THE EMERGENCY TREATMENT OF KNOWN OR SUSPECTED OPIOID OVERDOSE, AS MANIFESTED BY RESPIRATORY AND/OR CENTRAL NERVOUS SYSTEM DEPRESSION; INTENDED FOR IMMEDIATE ADMINISTRATION AS EMERGENCY THERAPY IN SETTINGS WHERE OPIOIDS MAY BE PRESENT; NOT A SUBSTITUTE FOR EMERGENCY MEDICAL CARE; FOR INTRANASAL USE ONLY; EACH NASAL SPRAY DELIVERS 4 MILLIGRAMS OF NALOXONE HYDROCHLORIDE SUPPLIED AS A SINGLE 4 MG DOSE OF NALOXONE HYDROCHLORIDE IN A 0.1 ML INTRANASAL SPRAY; STORE AT CONTROLLED ROOM TEMPERATURE 59 F TO 77 F (15 C TO 25 C); EXCURSIONS PERMITTED UP TO 104 F (40 C); DO NOT FREEZE; PROTECT FROM LIGHT; Protective Storage Feature: CONTROLLED ROOM TEMPERATURE; Part Name Assigned by Controlling Agency: NARCAN NASAL SPRAY. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.